BlackRock Fund Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $355M | Buy |
4,288,652
+239,180
| +6% | +$19.8M | 0.07% | 314 |
|
|
2016
Q3 | $375M | Buy |
4,049,472
+312,016
| +8% | +$28.9M | 0.08% | 262 |
|
|
2016
Q2 | $291M | Buy |
3,737,456
+54,123
| +1% | +$4.21M | 0.06% | 336 |
|
|
2016
Q1 | $304M | Buy |
3,683,333
+193,224
| +6% | +$15.9M | 0.07% | 302 |
|
|
2015
Q4 | $366M | Sell |
3,490,109
-345,791
| -9% | -$36.2M | 0.08% | 228 |
|
|
2015
Q3 | $404M | Buy |
3,835,900
+248,606
| +7% | +$26.2M | 0.1% | 174 |
|
|
2015
Q2 | $491M | Buy |
3,587,294
+203,545
| +6% | +$27.8M | 0.12% | 144 |
|
|
2015
Q1 | $422M | Buy |
3,383,749
+431,829
| +15% | +$53.8M | 0.1% | 188 |
|
|
2014
Q4 | $267M | Buy |
2,951,920
+5,012
| +0.2% | +$453K | 0.07% | 313 |
|
|
2014
Q3 | $213M | Buy |
2,946,908
+112,520
| +4% | +$8.12M | 0.06% | 357 |
|
|
2014
Q2 | $176M | Sell |
2,834,388
-9,771
| -0.3% | -$608K | 0.05% | 459 |
|
|
2014
Q1 | $194M | Buy |
2,844,159
+183,450
| +7% | +$12.5M | 0.06% | 396 |
|
|
2013
Q4 | $187M | Buy |
2,660,709
+123,939
| +5% | +$8.72M | 0.06% | 404 |
|
|
2013
Q3 | $183M | Buy |
2,536,770
+312,495
| +14% | +$22.6M | 0.06% | 364 |
|
|
2013
Q2 | $124M | Buy |
+2,224,275
| New | +$124M | 0.05% | 501 |
|